Is JUNS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for JUNS. It does not provide personalized investment advice.

JUNS (Jupiter Neurosciences, Inc. Common Stock) Stock Analysis - Financials

Jupiter Neurosciences, Inc. Common Stock (JUNS) is a publicly traded Healthcare sector company. As of July 7, 2026, JUNS trades at $0.21 with a market cap of $10.75M and a P/E ratio of -0.91. JUNS moved -4.48% today. Year to date, JUNS is -79.50%; over the trailing twelve months it is -86.59%. Its 52-week range spans $0.17 to $19.51. Rallies surfaces JUNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are JUNS's key financials?

JUNS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. JUNS recently traded at $0.21. Market cap is $10.75M. P/E ratio is -0.91. Revenue is $21.80K.

JUNS Key Metrics

Key financial metrics for JUNS
Metric	Value
Price	$0.21
Market Cap	$10.75M
P/E Ratio	-0.91
EPS	$-0.25
Dividend Yield	0.00%
52-Week High	$19.51
52-Week Low	$0.17
Volume	1.00M
Avg Volume	0
Revenue (TTM)	$21.80K
Net Income	$-8.64M
Gross Margin	0.00%

JUNS Analyst Consensus

JUNS analyst coverage data. Average price target: $0.00.

Common questions about JUNS

What are JUNS's key financials?: JUNS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. JUNS recently traded at $0.21. Market cap is $10.75M. P/E ratio is -0.91. Revenue is $21.80K.
Is JUNS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for JUNS. It does not provide personalized investment advice.